iiinova — where your digital self keeps evolving

Cochrane Hypertension @cochranehtn.bsky.social · 29/09/2026

🆕 #Cochrane Hypertension protocol 🆕 Blood pressure targets for hypertension in people with diabetes mellitus: doi.org/10.1002/1465... #hypertension #bloodpressure #diabetes

021

Cochrane Hypertension @cochranehtn.bsky.social · 04/09/2026

ICYMI- UPDATED review: Long‐term effects of weight‐reducing drugs in people with #hypertension www.cochranelibrary.com/cdsr/doi/10.... 👉🏼8 RCTs, 13,000+ people 👉🏼Evidence for people w/ HTN insufficient regarding benefits of pharmacological weight loss on risk of mortality or cardiovascular morbidity

020

Reposted by Cochrane Hypertension

The Cochrane Collaboration @cochrane.org · 17/08/2026

🫱🏾‍🫲🏿 An important principle of Cochrane reviews is involving people. Did you know Cochrane has a free learning resource to support you in getting people involved in the production of your reviews? Start learning today! 🔗 www.cochrane.org/learn/course...

Involving people. Discover best practice and practical suggestions for finding and involving people throughout the review process

033

Cochrane Hypertension @cochranehtn.bsky.social · 18/08/2026

🚨ICYMI: Cochrane Review update Pharmacotherapy for mild #hypertension www.cochranelibrary.com/cdsr/doi/10.... In ppl w/ mildly elevated #BloodPressure (BP) w/out cardiovascular disease or related health risks, BP meds may not reduce risk of death or of developing major CVD #SystematicReview

013

Reposted by Cochrane Hypertension

The Cochrane Collaboration @cochrane.org · 24/07/2026

Get involved in the #WorldEBHCDaycampaign by submitting a blog, short video, or hosting an event. By taking part in these eligible campaign activities, you or your organization may also be recognized as a @worldebhcday.bsky.social Evidence Ambassador. Learn how: worldebhcday.org/become-an-ev...

Become an Evidence Ambassador #WordlEBHCDay
worldebhcday.org
World Evidence-based Healthcare Day

022

Reposted by Cochrane Hypertension

Therapeutics Initiative (TI) @drug-evidence.bsky.social · 23/07/2026

🆕 POSTDOCTORAL RESEARCH FELLOW 🆕 The Therapeutics Initiative at UBC seeks a full-time postdoctoral fellow for an initial appointment of 1 year with the possibility of renewal Details + application link: ubc.wd10.myworkdayjobs.com/en-US/ubcfac... #JoinUs #Postdoctoraljobs #ResearchJobs

static.klipy.com

Sixt Recrutement: Nous recrutons !

ALT: Sixt Recrutement: Nous recrutons !

031

Cochrane Hypertension @cochranehtn.bsky.social · 29/06/2026

ICYMI: UPDATED review: Long‐term effects of weight‐reducing drugs in people with #hypertension www.cochranelibrary.com/cdsr/doi/10.... 👉🏼 8 RCTs, 13,000+ people 👉🏼Evidence for people w/ HTN insufficient regarding benefits of pharmacological weight loss on risk of mortality, cardiovascular morbidity

010

Cochrane Hypertension @cochranehtn.bsky.social · 25/06/2026

🆕 UPDATED review: Long‐term effects of weight‐reducing drugs in people with #hypertension www.cochranelibrary.com/cdsr/doi/10.... 👉🏼 8 RCTs, 13,000+ people 👉🏼Evidence for people w/ HTN insufficient regarding benefits of pharmacological weight loss on risk of mortality or cardiovascular morbidity

020

Reposted by Cochrane Hypertension

The Cochrane Collaboration @cochrane.org · 23/06/2026

We have strengthened how we identify and manage retracted publications associated with studies included in published or identified in ongoing Cochrane reviews. Find out more: www.cochrane.org/about-us/new... #ResearchIntegrity #EvidenceSynthesis

Magnifying glass on a stack of paper. Text reads: "Cochrane strengthens systems to manage retracted publications in its published reviews"

011

Cochrane Hypertension @cochranehtn.bsky.social · 24/06/2026

110

Cochrane Hypertension @cochranehtn.bsky.social · 25/05/2026

🚨ICYMI: Cochrane #hypertension review: #Riboflavin supplements for blood pressure lowering in adults www.cochranelibrary.com/cdsr/doi/10.... 🤔 Very uncertain evidence for effect of riboflavin on #bloodpressure 🎯 Large, well‐conducted trials needed #SystematicReviews #CochraneEvidence

010

Cochrane Hypertension @cochranehtn.bsky.social · 25/05/2026

010

Cochrane Hypertension @cochranehtn.bsky.social · 27/04/2026

010

Cochrane Hypertension @cochranehtn.bsky.social · 24/04/2026

cochranelibrary.com

Pharmacotherapy for mild hypertension - Wang, D - 2025 | Cochrane Library

Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.

020

Cochrane Hypertension @cochranehtn.bsky.social · 22/04/2026

020

Cochrane Hypertension @cochranehtn.bsky.social · 22/04/2026

🚨@cochrane.org Review update Pharmacotherapy for mild #hypertension www.cochranelibrary.com/cdsr/doi/10.... In ppl w/ mildly elevated #BloodPressure (BP) w/out cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD #SystematicReview

010

Cochrane Hypertension @cochranehtn.bsky.social · 22/04/2026

010

Cochrane Hypertension @cochranehtn.bsky.social · 22/04/2026

🚨ICYMI - Updated Cochrane #SystematicReview: Withdrawal of antihypertensive drugs in older people 💊 doi.org/10.1002/1465... "Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio" #CochraneEvidence #bloodpressure #deprescribing

010

Cochrane Hypertension @cochranehtn.bsky.social · 02/03/2026

020

Reposted by Cochrane Hypertension

deprescribing.org @deprescribing.bsky.social · 08/01/2026

🌍 Antihypertensives are among the commonly prescribed medications globally. Read about a recently-published systematic review & meta-analysis on #deprescribing antihypertensive medications in older people, conducted together with our collaborators here: buff.ly/CPznF05

067

Cochrane Hypertension @cochranehtn.bsky.social · 24/12/2025

🆕 Cochrane #hypertension review: #Riboflavin supplements for blood pressure lowering in adults www.cochranelibrary.com/cdsr/doi/10.... 🤔 Very uncertain evidence for effect of riboflavin on #bloodpressure 🎯 Large, well‐conducted trials needed #SystematicReviews #CochraneEvidence

010

Reposted by Cochrane Hypertension

The Cochrane Collaboration @cochrane.org · 23/12/2025

Too good to be true? Spotting problematic trials in systematic reviews | Online 🗓️26 February This interactive webinar will introduce the INSPECT-SR tool by way of application to a published clinical trial. 🔗Register here: evidencesynthesisireland.ie/conference/w...

evidencesynthesisireland.ie

Webinar: Dr Jack Wilkinson - Too good to be true? Spotting problematic trials in systematic reviews

To register, CLICK HERE IN COLLABORATION WITH THE EUROPEAN METHODS WEBINAR SERIES Systematic reviews of randomized controlled

101

Cochrane Hypertension @cochranehtn.bsky.social · 15/10/2025

010

Cochrane Hypertension @cochranehtn.bsky.social · 15/10/2025

🆕Review update🆕 Pharmacotherapy for mild #hypertension cochranelibrary.com/cdsr/doi/10.... In people with mildly elevated #BloodPressure (BP) without cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD #SystematicReview

010

Cochrane Hypertension @cochranehtn.bsky.social · 25/09/2025

🆕 @cochrane.org Review update 🆕 Pharmacotherapy for mild hypertension www.cochranelibrary.com/cdsr/doi/10.... In ppl w/ mildly elevated blood pressure (BP) w/out cardiovascular disease (CVD) or related health risks, BP meds may not reduce risk of death or of developing major CVD #SystematicReview

cochranelibrary.com

Pharmacotherapy for mild hypertension - Wang, D - 2025 | Cochrane Library

Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.

031

Reposted by Cochrane Hypertension

The Cochrane Collaboration @cochrane.org · 23/09/2025

Clearer, more consistent Cochrane reviews are coming. From mid-November, we’re updating reporting formats to make reviews easier to use, more accessible, and more impactful. 🔗 www.cochrane.org/about-us/new...

011

Reposted by Cochrane Hypertension

The Cochrane Collaboration @cochrane.org · 29/08/2025

Too good to be true? Spotting problematic trials in systematic reviews | Online 🗓️ 26 February This interactive webinar will introduce the INSPECT-SR tool by way of application to a published clinical trial. 🔗 evidencesynthesisireland.ie/conference/w...

evidencesynthesisireland.ie

Webinar: Dr Jack Wilkinson - Too good to be true? Spotting problematic trials in systematic reviews

To register, CLICK HERE Systematic reviews of randomized controlled trials (RCTs) aim to include all eligible

022

Reposted by Cochrane Hypertension

The Cochrane Collaboration @cochrane.org · 29/08/2025

Getting involved in health research reviews: a course for the public | Online 🗓️ 15 September Are you a patient, caregiver, or member of the public interested in contributing to health research? This 6-week, self-paced course from Cochrane Ireland is for you. 🔗 www.eventbrite.ie/e/getting-in...

eventbrite.ie

Getting Involved in Health Research Reviews: A Course for the Public

Designed for the public and helps you build the knowledge and skills to contribute to research teams conducting health research reviews.

121

Reposted by Cochrane Hypertension

The Cochrane Collaboration @cochrane.org · 29/08/2025

📣 We're rounding up a few dates for your diary. Discover these events being run by our global network of Cochrane Groups – a thread 🧵

112

Cochrane Hypertension @cochranehtn.bsky.social · 02/09/2025

ICYMI - Cochrane #SystematicReview 🎺 Renin inhibitors versus angiotensin receptor blockers for primary #hypertension doi.org/10.1002/1465... #CochraneEvidence #Blogshot

010

Cochrane Hypertension @cochranehtn.bsky.social · 10/06/2025

277

Reposted by Cochrane Hypertension

deprescribing.org @deprescribing.bsky.social · 10/05/2025

Also check out our complementary #deprescribing resources to reduce potentially inappropriate medications found here: deprescribing.org/resources/de...

deprescribing.org

Deprescribing Guidelines and Algorithms - Deprescribing.org

012

Cochrane Hypertension @cochranehtn.bsky.social · 12/05/2025

032

Cochrane Hypertension @cochranehtn.bsky.social · 21/04/2025

🆕 We've published a new Cochrane #SystematicReview protocol: Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists doi.org/10.1002/1465...

031

Reposted by Cochrane Hypertension

CADeN | ReCAD @caden-recad.bsky.social · 15/04/2025

SR & MA findings: very few (<10%) clinical trials report adverse drug withdrawal event (ADWE) following #deprescribing, and reporting methods are inconsistent. Standardizing reporting is needed to generate more robust evidence on deRXing and ADWEs: agsjournals.onlinelibrary.wiley.com/doi/10.1111/...

134

Reposted by Cochrane Hypertension

Therapeutics Initiative (TI) @drug-evidence.bsky.social · 15/04/2025

ICYMI: #BestEvidence webinar recording Debunking some of the hype in #hypertension ti.ubc.ca/drugevidence24 Dr. James Wright summarizes latest evidence on #antihypertensives ⏰ chronotherapy 💊 first line tx 🎯 BP targets ⚠️ tx efficacy + safety #DrugEvidence24 #MedEd #medsafety

youtube.com

Dr. James (Jim) Wright: Debunking some of the hype In hypertension

YouTube video by Therapeutics Initiative

064

Cochrane Hypertension @cochranehtn.bsky.social · 11/04/2025

🚨Updated Cochrane #SystematicReview: Withdrawal of antihypertensive drugs in older people 💊 doi.org/10.1002/1465... "Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio" #CochraneEvidence #bloodpressure #deprescribing

031

Reposted by Cochrane Hypertension

Therapeutics Initiative (TI) @drug-evidence.bsky.social · 11/04/2025

🧵 #ExercisePrescriptions 1/5 The TI’s Dr. Josh Levin asks: Clinicians, can you help your patients be more active? 🏃🏾‍♀️🏊🏾‍♂️ 🚶🏾‍♂️ 👉🏾Watch Dr. Levin’s presentation: www.youtube.com/watch?v=G5he... #Exercise #prescribing #ExerciseRx

youtube.com

Dr. Josh Levin: Exercise prescriptions - Evidence and clinical applications

YouTube video by Therapeutics Initiative

132

Cochrane Hypertension @cochranehtn.bsky.social · 01/04/2025

🆕 Cochrane #SystematicReview 🆕 Effect of adrenergic agonist oral #decongestants on blood pressure: www.cochranelibrary.com/cdsr/doi/10.... #CochraneEvidence #blogshot #bloodpressure

034

Cochrane Hypertension @cochranehtn.bsky.social · 31/03/2025

🆕 Cochrane #SystematicReview 🆕 Effect of #amphetamines on blood pressure: www.cochranelibrary.com/cdsr/doi/10.... #CochraneEvidence #blogshot #bloodpressure

032

Cochrane Hypertension @cochranehtn.bsky.social · 24/03/2025

ICYMI - Cochrane #SystematicReview 🎺 Renin inhibitors versus angiotensin receptor blockers for primary #hypertension doi.org/10.1002/1465... #CochraneEvidence #Blogshot

031

Cochrane Hypertension @cochranehtn.bsky.social · 12/03/2025

🚨ICYMI - Cochrane #SystematicReview Renin inhibitors versus angiotensin receptor blockers for primary #hypertension doi.org/10.1002/1465... #CochraneEvidence #Blogshot

063

Cochrane Hypertension @cochranehtn.bsky.social · 04/03/2025

Cochrane #SystematicReview 🎺 Renin inhibitors versus angiotensin receptor blockers for primary #hypertension doi.org/10.1002/14651858.CD012570.pub2 #CochraneEvidence #Blogshot

050

Cochrane Hypertension @cochranehtn.bsky.social · 04/03/2025

#BestEvidence webinar recording Debunking some of the hype in #Hypertension ti.ubc.ca/drugevidence24 Dr. James Wright summarizes latest evidence on #antihypertensives: ⏰ chronotherapy 💊 first line tx 🎯 blood pressure targets ⚠️ treatment efficacy + safety #drugevidence24 #meded #medsafety

youtu.be

Dr. James (Jim) Wright: Debunking some of the hype In hypertension

YouTube video by Therapeutics Initiative

020

Cochrane Hypertension @cochranehtn.bsky.social · 27/02/2025

🎺 Cochrane #SystematicReview 🚨 Renin inhibitors versus angiotensin receptor blockers for primary #hypertension doi.org/10.1002/1465... #CochraneEvidence #Blogshot

051

Cochrane Hypertension @cochranehtn.bsky.social · 27/02/2025

🆕 Cochrane #SystematicReview 🎺 Renin inhibitors versus angiotensin receptor blockers for primary #hypertension doi.org/10.1002/1465... #CochraneEvidence

131

Cochrane Hypertension @cochranehtn.bsky.social · 24/02/2025

🆕 #BestEvidence webinar recording Debunking some of the hype in #Hypertension ti.ubc.ca/drugevidence24 Dr. James Wright summarizes latest evidence on #antihypertensives: ⏰ chronotherapy 💊 first line tx 🎯 blood pressure targets ⚠️ treatment efficacy + safety #drugevidence24 #meded #medsafety

010